Anti-CD38 Antibody Treating Evans Syndrome

Clinical trial NCT06014775 · RECRUITING

Trial details

NCT number: NCT06014775
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Evan Syndrome Treatment

Start date: 2023-12-01
Primary completion: 2025-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.